Q2 2018 13F Holders as of 6/30/2018
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
170M
-
Number of holders
-
74
-
Total 13F shares, excl. options
-
31.8M
-
Shares change
-
-540K
-
Total reported value, excl. options
-
$274M
-
Value change
-
-$2.87M
-
Put/Call ratio
-
0.35
-
Number of buys
-
31
-
Number of sells
-
-32
-
Price
-
$8.60
Significant Holders of Seres Therapeutics, Inc. - COMMON STOCK (MCRB) as of Q2 2018
88 filings reported holding MCRB - Seres Therapeutics, Inc. - COMMON STOCK as of Q2 2018.
Seres Therapeutics, Inc. - COMMON STOCK (MCRB) has 74 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 31.8M shares
of 170M outstanding shares and own 18.66% of the company stock.
Largest 10 shareholders include Flagship Pioneering Inc. (12.7M shares), FMR LLC (6.1M shares), ARK Investment Management LLC (3.27M shares), BlackRock Inc. (2.24M shares), FEDERATED INVESTORS INC /PA/ (1.77M shares), VANGUARD GROUP INC (1.42M shares), RENAISSANCE TECHNOLOGIES LLC (732K shares), JPMORGAN CHASE & CO (396K shares), STATE STREET CORP (366K shares), and D. E. Shaw & Co., Inc. (289K shares).
This table shows the top 74 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.